Back to search
FDAFDA · Food and drugs·Recall number D-0926-2023

SUCCINYLcholine Chloride 200 mg/10mL (20 mg/mL), 10 mL BD Syringe, Rx Only, Advanced Compounding Solutions, 4 Constitution Way Ste L Woburn, MA 01801-1042; NDC: 71546-083-10

Published July 26, 2023 · Recall initiated: July 10, 2023

Summary

FDA records drug Class II recall D-0926-2023, published July 26, 2023 and initiated July 10, 2023. Recalling firm: New England Life Care, Inc. dba Advanced Compounding Solutions; Status: Terminated; Reported quantity: 493 syringes; Lot: Lot # 20230524-23C29D, Exp 21SEP2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Violations- that spaces adjacent to the production area may have been compromised at the time of production.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
New England Life Care, Inc. dba Advanced Compounding Solutions
Distributor
Nationwide in the USA
Lot
Lot # 20230524-23C29D, Exp 21SEP2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was SUCCINYLcholine Chloride 200 mg/10mL (20 mg/mL), 10 mL BD Syringe, Rx Only, Advanced Compounding Solutions, 4 Constitution Way Ste L Woburn, MA 01801-1042; NDC: 71546-083-10 recalled?

Yes. FDA published recall D-0926-2023 on July 26, 2023. Reported hazard: CGMP Violations- that spaces adjacent to the production area may have been compromised at the time of production.

What should I do if I have this product?

Voluntary: Firm initiated · Letter